Mangoceuticals, Inc.
MGRX
$0.15
Change (1 day)
$16.80
Year High
$2.10
Year Low
Categories
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
P/E ratio for Mangoceuticals, Inc. (MGRX)
P/E ratio as of 2023: -0.64
According to Mangoceuticals, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.64. At the end of 2022 the company had a P/E ratio of -519.96.
P/E ratio history for Mangoceuticals, Inc. from 2021 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -0.64 |
| 2022 | -519.96 |
| 2021 | -58691.60 |